A guide to the pharmacology of placebos.
- 15 April 1983
- journal article
- clinical trial
- Vol. 128 (8) , 921-5
Abstract
The placebo effect is capable of relieving pain in a substantial proportion of patients; affective disorders also respond to the administration of inert medication. Changes in objective measures, such as blood pressure and blood glucose levels, demonstrate the action of placebos. The underlying mechanisms are not yet known, but because the nature and strength of the placebo response are governed by the patient's perceptions, both positive and negative results may be obtained. The complexity of human perception has made it extremely difficult to characterize the people who react. In clinical situations the placebo may be underused as a therapeutic agent, while in clinical trials the effect may be inadequately evaluated; the power and nature of the placebo effect truly warrant greater recognition.This publication has 51 references indexed in Scilit:
- RanitidineDrugs, 1982
- Zomepirac Sodium in the Treatment of Primary Dysmenorrhea SyndromeNew England Journal of Medicine, 1982
- The Premenstrual SyndromeDrugs, 1982
- Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patientsAmerican Heart Journal, 1982
- THE MECHANISM OF PLACEBO ANALGESIAThe Lancet, 1978
- Clonidine Prophylaxis of Childhood Migraine and Other Vascular HeadacheHeadache: The Journal of Head and Face Pain, 1977
- The Ethics of Giving PlacebosScientific American, 1974
- New aspects of the placebo response in angina pectorisThe American Journal of Cardiology, 1969
- Some Comments on Non-Drug Factors In Psychiatric Drug TherapyPsychosomatics, 1965
- The Placebo ResponseJournal of Mental Science, 1956